BARR GENERIC WARFARIN TO BE LAUNCHED IN SUMMER; DUPONT MERCK CONTINUES EFFORTS TO PASS STATE LAWS REQUIRING PHYSICIAN APPROVAL FOR NTI SUBSTITUTION
Executive Summary
Barr intends to launch its generic version of warfarin during the summer, the company said following FDA's March 26 approval of the first generic version of DuPont Merck's anticoagulant Coumadin.
You may also be interested in...
FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order
FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011